Join Empatica for the first webinar of our 2026 series, featuring Prof. K. Ray Chaudhuri, Professor of Neurology and Movement Disorders, Director of Research and Clinical Trials at King’s College Hospital London, Dubai, Chair of the International PD Non Motor Group, alongside Empatica leadership.

In this session, we introduce a new integrated approach to objective Parkinson’s monitoring, combining the clinically validated PKG algorithms with Empatica’s FDA-cleared wearable technology and scalable digital health infrastructure. Together, we will explore how continuous, real-world monitoring can strengthen clinical decision-making, enable more robust research, and improve the patient experience.
 

What we cover:

  • Prof. Chaudhuri's experience with adoption in routine practice, including patient onboarding, compliance, and real-world use cases
  • How objective motor-fluctuation data can better inform treatment optimization
  • The advantages over traditional clinic-based assessments
  • An exclusive first look at the Empatica Health Monitoring Platform for Parkinson’s
  • Audience Q&A with the speakers
     

Watch our webinar
Explore how Empatica is evolving objective Parkinson’s monitoring within a broader digital health platform designed for modern clinical care and research.

Get access

By clicking Access Webinar you consent to being contacted by Empatica Inc. about its products and services and you agree to the terms and conditions stated in the privacy policy.

Our special guest

Professor K. Ray Chaudhuri is Director of Research and Clinical Trials at King's College Hospital, London, Dubai. Ex-Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and Ex-Director of the Parkinson Foundation International Centre of Excellence at King’s College Hospital in London. He is founder of MDS Nonmotor PD Study group (NMSG), Ex Chairman and now steering group of the Industry Engagement Committee, and Co Chair Task force of the Parkinson Wellness committee of the Movement Disorders Society (MDS) was a member of the MDS Congress Scientific Programme Committee (2013-2017) and is Founder-Editor-in-Chief of the njp Parkinson’s Disease, and current Editor Front. Aging Neurosci. - Parkinson’s Disease and Aging-related Movement Disorders and a founder member of King's Parkinson’s Charity. He is an advisor to NHS England, the General Medical Council, as well as Parkinson’s UK and Parkinson’s Europe. Professor Chaudhuri is the author of over 650 articles (Scopus listed), with H index > 100, co-editor of 7 books on Parkinson’s disease and restless legs syndrome, and winner of the British Medical Association Book Awards commendation in 2015 and 2017. He is also the recipient of the 2018 Jay Van Andel Award Outstanding Achievement in Parkinson’s Disease Research (pioneering holistic assessments and non-motor subtypes), as well as National Institute for Health Research/Royal College of Physicians award for outstanding research leadership in 2017. He was elected an honorary member of the Movement Disorders Society in 2021, Honorary Professor at Brasov University and received the UK NHS Gold merit award in 2021 for excellence in research and clinical service. In 2023, he was featured as a “role model” in the British Medical Journal. He has been a guest lecturer worldwide, including in Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, the US, Russia, and Europe. In 2025, he is ranked within the top 2% of all scientists in the world (Stanford and Elsevier ranking) and in 2024, an independent review in the Frontiers journal by LI et al rated KRC as the one with the most publications globally in nonmotor Parkinson’s since 2013 (Li et al, DOI 10.3389/fnagi.2024.1335550). He is a member of the Parkinson's UK project grants College of Experts and a reviewer of USA Congressionally Directed Medical Research Programs (U.S. Army Medical Research Acquisition Activity (USAMRAA) ), NIH and Middle East grant programmes such as Dubai Health Authority and Saudi Arabia Grants Committee (RDIA grants programme).

 

Our hosts

 

About Empatica

Empatica Inc. is a pioneer in continuous, unobtrusive remote health monitoring driven by AI. 
Empatica's FDA-cleared platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. Its flagship medical wearable, EmbracePlus, has been developed with key partners including HHS, USAMRDC, and the NASA-funded TRISH. Its latest device, EmbraceMini, is the world’s smallest actigraphy device for use in clinical care and research. Empatica is also a global leader in patient-centric wearable epilepsy monitoring. In 2025, Empatica acquired PKG Health, expanding its offering into Parkinson’s Disease.